Preimplantation Genetic Testing Market, By Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Technology (Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers and Others), By Application (Aneuploidy, Single Gene Disorders, HLA Typing, X-Linked Disorders, and Others), By End-Users (Research Laboratories, Fertility Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI506223 | Publish Date: February 2024 | No. of Pages: 170

Preimplantation Genetic Testing Market Overview

Preimplantation Genetic TestingMarket was valued at US$ 714.4 Million in 2024 and is projected to grow at a CAGR of 10.30%to reach US$ 1742.5 ,Million by 2034.

Preimplantation Genetic Testing (PGT) is the early form of prenatal diagnosis of genetic where an abnormal embryos are identified by allowing transfer of genetically normal embryos. Preimplantation Genetic Testing (PGT) technology has become an integral part of ART (Assisted Reproductive Technology) procedures. PGT test for around 400 different single-gene disorders which includes, sickle cell anemia, cystic fibrosis, Huntington’s disease, and Tay-Sachs. PGT also help in testing disorder that would be fatal to fetus and illness that may not affect child until they become older. PGT-A help in reducing the risk of having child with chromosomal abnormality. PGT-A help in reducing risk of future miscarriages in women who has unexplained miscarriages. PGT is performed before embryo transfer during IVF. Intended parents can determine gender through PGT-A, PGD, and PGS during IVF journey. PGT is done in laboratory by using IVF (In-vitro fertilization). Preimplantation Genetic Diagnosis (PGD) includes testing an embryo before it gets implanted for specific genetic disorder. Preimplantation Genetic Screening, includes testing an embryo for identification of any chromosomal abnormalities. Embryos with chromosomal abnormalities may lead to miscarriage or will not lead to a pregnancy. All men has some sperm which are chromosomally abnormal. Percentage of embryos which are abnormal are affected by age and health history of parents. PGT is done by different methods like Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers, etc. Newer techniques like genome sequencing and microarray has become common methods of genetic testing. Chromosomal abnormalities has dominated the target market growth due to unhealthy lifestyle and poor nutrition food. It occurs usually when there is an error in cell division by following mitosis or meiosis. However, decreasing fertility rates has fueled the target market growth.

Preimplantation Genetic Testing Market Dynamics

Decreasing fertility rates and rate of urbanization is one of the leading factors for the Preimplantation Genetic Testing Market growth. Urbanization has caused unhealthy lifestyle, change in diet, obesity, lack of exercise, pollution, late marriages fewer children, no breast feeding or lesser feeding for less duration, early menarche, late menopause, which has become major contribution in target market growth. Numerous factors like rising age, late marriages, unhealthy lifestyle, poor nutrition food, obesity, alcohol intake, smoking, lack of exercise, can affect individual’s fertility rate. As woman age increases fertility rate gets decreasing because of reduction in number of eggs which remains in her ovaries. Higher education levels, especially of women and greater prosperity has given rise in late marriages and thus result in decrease in fertility. Urbanization is associated with higher economic development which leads to higher engagement in education and work and thus, result in fertility rates. Couples are delaying in starting a family which has led to truly decline in their fertility rates because of ageing ovarian and related reasons which lead to reduction in chance of conception.

For instance, according to (PMC) it was determined that urbanization is associated with lower fertility rate in developing countries. It was determined that urban women exhibit fertility rates on an average 11% lower than those of rural women. In urban women’s first birth occurs with 22% lower odds. Delayed union, education and employment costs and access to family planning services has result I decreased fertility. Urbanization has linked to declining fertility by broad social changes. Preimplantation Genetic Testing help in lowering risk of miscarriage and help in increasing chances of successful IVF (in-vitro fertilization) cycle at first transfer of embryo. However, decreasing fertility rate and growth of urban population has boost the demand for Preimplantation Genetic Testing market growth.

Restrains:

PGT has some limitations under certain circumstances. Mosaicism, subtelomeric deletions, microdeletions, small structural rearrangements, microduplications, may pose challenges. Experienced and skilled laboratory personnel in IVF and genetics is required and are important for patient’s success. Chances of embryo destruction during biopsy process stops growing and do not get proceed to next growth phase and thus, led to viable pregnancy. However, some limitations, technical challenges and expensive costs may restrain the target market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Preimplantation Genetic Testing Market Segmentation

 

The Preimplantation Genetic Testing market is segmented based on type, technology, application, end-users and region.

On the basis of type, the Preimplantation Genetic Testing market is segmented into Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis.  On the basis of technology, the Preimplantation Genetic Testing market is segmented into Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers and others.  On the basis of application, the target market is segmented into Aneuploidy, Single Gene Disorders, HLA Typing, X-Linked Disorders, and others. On the basis of end-users, the target market is segmented into Research Laboratories, Fertility Clinics, and others.

Regional Insights:

On region the Preimplantation Genetic Testing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising cases of chromosomal abnormalities, genetic disorders, well developed & robust healthcare infrastructure, advanced technological development in genetic testing, disposable income, is anticipated to increase demand for Preimplantation Genetic Testing in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

20243 – 2034

Market representation

Revenue in USD Million & CAGR from 2024 to 2034

Market Segmentation

By Type - Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis

By Technology - Polymerase Chain Reaction, Next Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Single Nucleotide Polymorphism, Validation Biomarkers and others

By Application – Aneuploidy, Single Gene Disorders, HLA Typing, X-Linked Disorders, and others

By End-Users - Research Laboratories, Fertility Clinics, and others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Preimplantation Genetic Testing Market report based on type, technology, application, end-users and region.

Preimplantation Genetic Testing Market, By Type:

  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis

Preimplantation Genetic Testing Market, By Technology:

  • Polymerase Chain Reaction
  • Next Generation Sequencing
  • Comparative Genomic Hybridization
  • Fluorescence In-Situ Hybridization
  • Single Nucleotide Polymorphism
  • Validation Biomarkers
  • Others

Preimplantation Genetic Testing Market, By Application:

  • Aneuploidy
  • Single Gene Disorders
  • HLA Typing
  • X-Linked Disorders
  • Others

Preimplantation Genetic Testing Market, By End-Users:

  • Research Laboratories
  • Fertility Clinics
  • Others

Preimplantation Genetic Testing Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Preimplantation Genetic Testing Market Key Players

The key players operating the Preimplantation Genetic Testing Market includes, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Illumina Inc., Perkin Elmer Inc., Agilent Technologies Inc., CooperSurgical Inc., Natera Inc., Bioarray S.L., MedGenome Labs Ltd., Eurofins Genoma and others.

Preimplantation Genetic Testing Market Key Issues Addressed

Recent Development:

  • In January 2023, MedGenome Labs Ltd., has announced that it is estimating inorganic growth for targeting emerging markets. The company is actively estimating other targets for Claria a suite of NGS (next generation sequencing) technology based on reproductive testing. Claria aims to offer most accurate Preimplantation Genetic Screening/Diagnosis (PGS-PGD), Non-invasive Prenatal Screening Test (NIPT), Genetic Carrier Screening Test (GCST), for testing unborn baby genes.
  • In September 2022, Eurofins Genoma has launched new ‘niPGT-A’, a non-invasive, embryo biopsy free, preimplantation genetic aneuploidy screening test. Newly launched ‘niPGT-A’ testing will help in providing IVF  centers with access to highly accurate which is alternative to traditional PGT-A testing by providing quality embryo samples & avoiding need for embryo biopsies.
  • In July 2020, Thermo Fisher Scientific has signed a strategic partnership agreement with First Genetics a Russian diagnostic equipment & IVD manufacturer for developing NGS (next generation sequencing) based diagnostics in Russia. First Genetics will market F-Genetics NGS (next generation sequencing) system and IVD assays for cancer diagnostics and reproductive health testing to Russian lab as per agreement. The company has secured approval for its new ‘Reproline’ kit to be used in diagnosing chromosomal abnormalities in embryos on F-Genetics NGS System which is prior to IVF implantation.
  • In October 2019, PerkinElmer has unveil the innovative genetic testing kit which will be an alternative to IVF embryo biopsies. PerkinElmer has introduced its new PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit. This kit will provide solution tests to spent embryo culture media for chromosomal abnormalities during IVF treatment and accurately detects aneuploidies.

Preimplantation Genetic Testing Market Company Profile

  • Thermo Fisher Scientific*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott Laboratories Inc.
  • Illumina Inc.
  • Perkin Elmer Inc.*
  • Agilent Technologies Inc.
  • CooperSurgical Inc.
  • Natera Inc.
  • Bioarray S L.
  • MedGenome Labs Ltd.*
  • Eurofins Genoma*

 “*” marked represents similar segmentation in other categories in the respective section

Preimplantation Genetic Testing Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Preimplantation Genetic Testing Market, By Type
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Preimplantation Genetic Screening
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Preimplantation Genetic Diagnosis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
  6. Preimplantation Genetic Testing Market, By Technology, 2022 – 2032, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Polymerase Chain Reaction
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Next Generation Sequencing
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Comparative Genomic Hybridization
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Fluorescence In-Situ Hybridization
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Single Nucleotide Polymorphism
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Validation Biomarkers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
  7. Preimplantation Genetic Testing Market, By Application, 2022 – 2032, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Aneuploidy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Single Gene Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • HLA Typing
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • X-Linked Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
  8. Preimplantation Genetic Testing Market, By End-Users, 2022 – 2032, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Research Laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Fertility Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
  9. Preimplantation Genetic Testing Market, By Region, 2022 – 2032, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  3. Company Profiles
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Perkin Elmer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • CooperSurgical Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Natera Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bioarray S.L.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • MedGenome Labs Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Eurofins Genoma
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Preimplantation Genetic Testing Market is segmented into type, technology, application, end-users and region.

Preimplantation Genetic Testing Market is driven by factors like decreasing fertility rates & rate of urbanization.

By region, the Preimplantation Genetic Testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.

The key players operating the Preimplantation Genetic Testing Market includes, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Illumina Inc., Perkin Elmer Inc., Agilent Technologies Inc., CooperSurgical Inc., Natera Inc., Bioarray S.L., MedGenome Labs Ltd., Eurofins Genoma and others.